Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth
Central Asia visit drives multi-sector collaboration, Business delegation signed 66 MoUs and agreements to seize Belt and Road opportunities
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement
Hyper Bit Technologies Announces Director Resignation and Provides Corporate Update
iFabric Corp. Announces Closing of $28 Million Bought Deal Offering
Company announcement – No. 76 / 2021 Zealand Pharma Announces Enrollment of Last Patient Needed…
Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development…
Gilles SCHNEPP takes over as Chairman of the Appointments, Governance and CSR Committee…
Press Release Nicox Announces First Patient in China screened in the ongoing NCX 470…
Initial results show excellent immune response after third dose of VLA2001 administered 7 to 8…
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
Ad hoc announcement pursuant to Art. 53 LR Share buyback of up to USD 15bn…
On December 15th, 2021 JSC Olainfarm has received announcement on substantial participation from AS AB…
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
LOS ANGELES, Dec. 15, 2021 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio” or the…
EWING, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”),…
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0…
Ji’an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
MONTRÉAL, Dec. 15, 2021 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX…
Lyell’s cGMP-compliant manufacturing facility, is designed to produce cell products at scale for upcoming clinical…
1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing…
WEST CHESTER, Pa., Dec. 15, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
SAN DIEGO, Dec. 15, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
MONMOUTH JUNCTION, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) — Elucida Oncology, a clinical-stage biotechnology company…
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA) today announced…